We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+16.33%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.37B
AUM Growth
+$227M
(+11%)
Cap. Flow
-$5.81M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
19.78%
Holding
359
New
114
Increased
58
Reduced
128
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BellRing Brands
BRBR
|
+$32M |
| 2 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$18M |
| 3 |
PRFT
Perficient Inc
PRFT
|
+$15.7M |
| 4 |
Axos Financial
AX
|
+$14.4M |
| 5 |
Ameris Bancorp
ABCB
|
+$13.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$33M |
| 2 |
CADE
Cadence Bancorporation
CADE
|
+$29.6M |
| 3 |
VG
Vonage Holdings Corporation
VG
|
+$15.7M |
| 4 |
ARQL
Arqule Inc
ARQL
|
+$15.6M |
| 5 |
Karyopharm Therapeutics
KPTI
|
+$14.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.26% |
| 2 | Consumer Discretionary | 16.72% |
| 3 | Industrials | 15.68% |
| 4 | Technology | 14.21% |
| 5 | Consumer Staples | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Citizens & Northern Corp
CZNC
$436M
| $244K | 0.01% |
8,645
| – | – |
|
|
KNL
227
DELISTED
Knoll, Inc.
KNL
| $242K | 0.01% |
9,580
| – | – |
|
228
WesBanco
WSBC
$3.95B
| $237K | 0.01% |
+6,274
| New | +$234K |
|
229
Global Payments
GPN
$22.1B
| $227K | 0.01% |
1,242
-31
| -2% | -$5.32K |
|
230
MasTec
MTZ
$26.7B
| $221K | 0.01% |
3,438
-1,431
| -29% | -$94.2K |
|
231
InMode
INMD
$872M
| $219K | 0.01% |
11,188
-39,298
| -78% | -$738K |
|
232
Merck
MRK
$324B
| $218K | 0.01% |
2,514
| – | – |
|
233
Blackstone
BX
$104B
| $209K | 0.01% |
+3,741
| New | +$194K |
|
|
LTHM
234
DELISTED
Livent Corporation
LTHM
| $208K | 0.01% |
24,353
| – | – |
|
235
Knight Transportation
KNX
$11.8B
| $203K | 0.01% |
5,676
-67
| -1% | -$2.46K |
|
|
TELL
236
DELISTED
Tellurian Inc.
TELL
| $180K | 0.01% |
24,731
| – | – |
|
237
Unisys
UIS
$227M
| $178K | 0.01% |
14,980
| – | – |
|
238
Adobe
ADBE
$89.5B
| $177K | 0.01% |
+538
| New | +$158K |
|
239
Wabtec
WAB
$51.1B
| $174K | 0.01% |
+2,241
| New | +$166K |
|
240
Axalta
AXTA
$7.01B
| $172K | 0.01% |
+5,650
| New | +$167K |
|
|
PWOD
241
DELISTED
Penns Woods Bancorp
PWOD
| $170K | 0.01% |
+4,773
| New | +$152K |
|
242
Arista Networks
ANET
$219B
| $162K | 0.01% |
+12,720
| New | +$167K |
|
243
Oil States International
OIS
$522M
| $161K | 0.01% |
9,859
-9,784
| -50% | -$149K |
|
|
AQUA
244
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $161K | 0.01% |
+8,470
| New | +$152K |
|
|
MOBL
245
DELISTED
MobileIron, Inc.
MOBL
| $158K | 0.01% |
32,613
| – | – |
|
246
Kinsale Capital Group
KNSL
$7.95B
| $146K | 0.01% |
+1,440
| New | +$143K |
|
247
Illumina
ILMN
$29.4B
| $142K | 0.01% |
+440
| New | +$133K |
|
248
Shenandoah Telecom
SHEN
$632M
| $138K | 0.01% |
+3,320
| New | +$118K |
|
|
HT
249
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $126K | 0.01% |
+8,652
| New | +$123K |
|
250
Knowles
KN
$3.22B
| $125K | 0.01% |
+5,892
| New | +$127K |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, Emerald Advisers held 359 positions worth $2.37B, up 11% from $2.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Emerald Advisers's Q4 2019 filing shows 114 new, 58 increased, 128 reduced and 21 closed positions. Its largest new stake was BellRing Brands: 1,634,376 shares worth $34.8M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $33M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Emerald Advisers's largest Q4 2019 buy was BellRing Brands: 1,634,376 shares worth $34.8M.
- Emerald Advisers added most to Perficient Inc in Q4 2019, an estimated $15.7M increase.
- Emerald Advisers's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $33M.
- Emerald Advisers fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $13.2M.
- Emerald Advisers's ten largest holdings make up 20% of its $2.37B portfolio in Q4 2019.
- Emerald Advisers opened 114 new positions and closed 21 in Q4 2019.
- Emerald Advisers's portfolio value rose 11% quarter-over-quarter to $2.37B.
Based on Emerald Advisers's 13F filing for Q4 2019, filed 29 Jan 2020.